Trial Profile
COMPARISON OF INTRANASAL CORTICOSTEROIDS WITH ALLERGEN AVOIDANCE FOR THE MANAGEMENT OF PERSISTENT RHINITIS.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- 03 Sep 2011 New trial record